#1 Clinical Trials Search in Europe

Tiapride

This article delves into the use of Tiapride in clinical trials, focusing on its applications in treating various disorders. Tiapride, a neuroleptic medication, has been studied for its potential benefits in conditions such as tic disorders, Huntington’s disease, and gerontopsychiatric disorders. We’ll examine the findings from different clinical trials to provide a comprehensive overview of Tiapride’s efficacy, safety, and potential applications in medical treatment.

Table of Contents

What is Tiapride?

Tiapride, also known by brand names such as Tiapridal, Tiapridex, or Tiapridel, is a medication that belongs to the class of drugs called neuroleptics[2]. Neuroleptics are a type of medication primarily used to treat various mental health and neurological conditions. Tiapride works by affecting certain chemicals in the brain, which helps to control movement disorders and other symptoms associated with certain conditions.

Uses of Tiapride

Tiapride is used to treat several conditions, including:

  • Tic Disorders: Tiapride is used in the treatment of tic disorders, including Tourette Syndrome and Chronic Tic Disorder. Tics are sudden, repetitive movements or sounds that a person makes, often uncontrollably[1].
  • Huntington’s Disease: This is a genetic disorder that causes progressive brain damage, affecting movement, behavior, and cognition. Tiapride is one of the medications used to manage symptoms of Huntington’s Disease, particularly the movement disorders associated with it[2].
  • Psychiatric Conditions: In some cases, Tiapride may be used in the treatment of various psychiatric disorders in elderly patients (gerontopsychiatric patients)[3].

Dosage Information

The dosage of Tiapride can vary depending on the condition being treated and the age of the patient. Here are some general guidelines based on the available information:

  • For Tic Disorders in Children and Adolescents:
    • For patients aged 5-12 years: Starting dose is typically 50mg twice daily for the first 2 weeks, then increased to 100mg twice daily for the next 6 weeks.
    • For patients aged 13-18 years: Starting dose is usually 100mg twice daily for the first 2 weeks, then increased to 200mg twice daily for the next 6 weeks[1].
  • For Huntington’s Disease: The dosage ranges from 300 to 800 mg per day, typically given in tablet form of 100 mg[2].

It’s important to note that these are general guidelines, and your doctor will determine the right dosage for you based on your individual condition and response to the medication.

Potential Side Effects

Like all medications, Tiapride can cause side effects. While not everyone experiences side effects, it’s important to be aware of potential adverse reactions. Common side effects may include drowsiness, dizziness, or changes in movement. In elderly patients, there may be an increased risk of side effects due to age-related changes in metabolism and the presence of other health conditions[3].

It’s crucial to report any unusual symptoms or side effects to your healthcare provider. They can help determine if these effects are related to the medication and adjust your treatment plan if necessary.

Ongoing Research

Tiapride continues to be the subject of clinical research to better understand its effectiveness and safety profile:

  • A study comparing Tiapride with other medications (Olanzapine and Tetrabenazine) in the treatment of Huntington’s Disease is ongoing. This research aims to evaluate the benefits and side effects of these medications over a 12-month period[2].
  • Another study is investigating the safety of various psychopharmacological treatments, including Tiapride, in elderly psychiatric patients. This research will help to better understand the potential risks and benefits of these medications in older adults[3].

These ongoing studies highlight the importance of continuous research to improve our understanding and use of medications like Tiapride.

Aspect Details
Conditions Studied Tic Disorders, Huntington’s Disease, Gerontopsychiatric Disorders
Dosage Forms Tablets (100 mg)
Dosage Range 300-800 mg per day (varies by study and patient characteristics)
Treatment Duration 8 weeks to 12 months (varies by study)
Comparison Medications Olanzapine, Tetrabenazine (in Huntington’s Disease study)
Outcome Measures Yale Global Tic Severity Scale (YGTSS), Independence Scale, Adverse Drug Reactions
Patient Populations Children and adolescents (Tic Disorders), Adults (Huntington’s Disease), Elderly (Gerontopsychiatric study)

FAQ

  • What is Tiapride and what conditions is it used to treat? Tiapride is a neuroleptic medication that has been studied for treating various conditions. In clinical trials, it has been used to treat tic disorders, Huntington's disease, and as part of treatment regimens for gerontopsychiatric patients. It's important to note that its use may vary depending on the specific condition and patient characteristics.
  • How is Tiapride administered in clinical trials? In the clinical trials reviewed, Tiapride was typically administered in tablet form. For example, in a study on Huntington's disease, Tiapride tablets of 100 mg were given, with dosages ranging from 300 to 800 mg per day. The specific dosage and frequency can vary based on the condition being treated and the patient's age and characteristics.
  • What are some potential side effects of Tiapride? While specific side effects were not detailed in the provided trial information, as with any medication, Tiapride may have potential side effects. In the gerontopsychiatric study, researchers were monitoring for adverse drug reactions, which suggests that side effects are a consideration when using Tiapride. It's always important to discuss potential side effects with a healthcare provider.
  • How does Tiapride compare to other medications in clinical trials? In some trials, Tiapride was compared to other medications. For instance, in a study on Huntington's disease, Tiapride was compared with Olanzapine and Tetrabenazine. The study aimed to compare the beneficial and adverse effects of these three different neuroleptics. However, the specific results of this comparison were not provided in the given information.
  • What is the duration of Tiapride treatment in clinical trials? The duration of Tiapride treatment varied in different clinical trials. In the tic disorder study, the treatment duration was 8 weeks. In the Huntington's disease study, patients were followed for 12 months. The specific duration of treatment may depend on the condition being treated and the design of the individual study.

Ongoing Clinical Trials on Tiapride

  • Study on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Tiapride: A neuroleptic medication used in the treatment of various disorders, including tic disorders and Huntington's disease. It's also known by brand names such as Tiapridal, Tiapridel, and Tiapridax.
  • Neuroleptic: A type of medication primarily used to manage psychosis. These drugs affect the brain's neurotransmitters to help control symptoms such as hallucinations, delusions, and disordered thinking.
  • Tic Disorder: A group of conditions characterized by sudden, repetitive, nonrhythmic motor movements or vocalizations. Tourette syndrome is an example of a tic disorder.
  • Huntington's Disease: A genetic disorder that causes progressive brain damage, leading to uncontrolled movements, emotional problems, and loss of thinking ability.
  • Gerontopsychiatric: Relating to the branch of medicine dealing with mental disorders in older adults.
  • Yale Global Tic Severity Scale (YGTSS): A scale used to measure the severity of tic symptoms in individuals with tic disorders.
  • Placebo: A substance with no active therapeutic effect, used as a control in testing new drugs to determine their effectiveness.
  • Adverse Drug Reaction: An unwanted or harmful reaction experienced following the administration of a drug or combination of drugs.
  • Polypharmacy: The simultaneous use of multiple drugs by a single patient, often to treat one or more medical conditions.
  • Pharmacovigilance: The practice of monitoring the effects of medical drugs after they have been licensed for use, especially to identify and evaluate previously unreported adverse reactions.

References

  1. https://clinicaltrials.gov/study/NCT01501695
  2. https://clinicaltrials.gov/study/NCT00632645
  3. https://clinicaltrials.gov/study/NCT02374567